| Officer | Age | In this role | Joined | 2025 pay | Source |
|---|---|---|---|---|---|
|
Anh T. Nguyen
Chief Medical Officer
|
51 |
Since 2025
1 year
|
Not stated | Not reported | |
|
John Shannon
Also a director
See Remarks
Title from the Form 4 dated Aug 1, 2026
|
64 | Not stated | 2017 | $5,042,584 | |
|
Steven M. Pieper
See Remarks
Title from the Form 4 dated Nov 2, 2026
|
49 | Not stated | 2017 | $1,874,090 | |
|
Kevin McCulloch
See Remarks
Title from the Form 4 dated Nov 5, 2026
|
63 | Not stated | 2018 | $2,270,973 | |
|
Beth P. Hecht
See Remarks
Title from the Form 4 dated Nov 2, 2026
|
62 | Not stated | 2018 | $1,895,274 |
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
From the proxy statement filed Apr 23, 2026 · updated by the 8-Ks of Jun 30, 2026 and Nov 2, 2026
| Director | Age | On board | Independent | Committees | Other public boards | 2025 pay | Source |
|---|---|---|---|---|---|---|---|
|
Marla Persky
Board chair
|
70 |
2021
5 years
|
Independent |
Audit Committee
Nominating and Corporate Governance Committee
|
Revolo Biotherapeutics Limited | $326,500 | |
|
John Shannon
CEO
|
64 |
2024
2 years
|
Not independent | None stated | None stated | Paid as CEO | |
|
Dawn Halkuff
|
55 |
2021
5 years
|
Independent |
Compensation Committee
|
None stated | $290,500 | |
|
John Johnson
|
68 |
2021
5 years
|
Independent |
Nominating and Corporate Governance Committee
|
Verastem, Inc., AxoGen, Inc. | $276,500 | |
|
BJ Bormann
|
67 |
2021
5 years
|
Independent |
Nominating and Corporate Governance Committee
|
BioLine Rx Ltd., NanoMedical Systems Inc. | $294,500 | |
|
James Brady
|
63 |
2025
1 year
|
Independent | None stated | None stated | $606,984 | |
|
Garheng Kong
|
50 |
2021
5 years
|
Independent |
Audit Committee
|
Laboratory Corporation of America Holdings, Lunit, Inc., Smith+Nephew | $281,500 | |
|
Nerissa Kreher
Joined Jul 1, 2026
|
- | - | Independent | - | - | - | |
|
Menassie Taddese
Joined Nov 2, 2026
|
- | - | Independent |
Audit Committee
|
- | - | |
|
Jeffrey Sherman
Leaving at the meeting
|
Not stated | Not stated | Independent |
Compensation Committee
Nominating and Corporate Governance Committee
|
None stated | $285,500 |
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive. A director marked Joined was added by an 8-K; their row opens that 8-K, and a dash is a value it does not give.
The proxy filed Apr 23, 2026 describes a review policy but reports no transactions.
Read the policy in the proxyLoading...